BWAY: BrainsWay Ltd Net earnings per share growth forecast for next year

The exclusivity of Deep TMS patents provides BrainsWay Ltd. (BWAY) with significant pricing power amid inelastic demand. Its monopolist status in the non-invasive brain stimulation niche is confirmed by the forward earnings per share dynamics, where 70.80 describes the current status of the metric. Technological development relies on the implementation of AI systems and the robotization of electromagnetic module assembly to ensure precise device calibration.

BWAY - BrainsWay Ltd Expected earnings per share growth for next year over the range 07/04/2022 - 11/15/2026

Metric breakdowns and analytics for BrainsWay Ltd. (BWAY)

- price and consensus price forecast:

Price Chart BrainsWay|BWAY - Broker Consensus Forecast

- market capitalization information:

Market Value BrainsWay Ltd.|BWAY - Company Buyout Price

- company book value details:

Accounting Value per Share BrainsWay|BWAY - Company Net Assets|Market Capitalization to Book Value Ratio brainsway.com|BWAY - Company Total Assets

- debt and liquidity data:

- earnings and market ratios statistics:

BWAY - Company Profit|Future Profit BrainsWay Ltd.|BWAY - Business Payback Period|Forward P/E Multiple BrainsWay Ltd.|BWAY - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio BrainsWay Limited|BWAY - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) BrainsWay|BWAY - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months brainsway.com|BWAY - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year BrainsWay Ltd.

- sales volume and revenue indicators:

BWAY - Company Annual Revenue|Company Projected Revenue BrainsWay|BWAY - Price-to-Revenue Coefficient|Forward Price-to-Revenue Multiple BrainsWay

Fundamental company valuation:BWAY, BrainsWay

Stable capacity utilization for BrainsWay Ltd. (BWAY) neurostimulator assembly creates a foundation for predictable cash flow. The algorithm aggregates expert earnings per share expectations, forming the calculated value 70.80. This metric measures future EPS growth rates, allowing investors to assess the market consensus regarding business scaling. The forward-looking EPS estimate trend on the GURU.Markets platform visualizes the dynamics of these fundamental model revisions.

Key competitors

ACHC (acadiahealthcare.com) - Earnings growth forecast for next year|LifeStance Health (LFST) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Nexalin (NXL)